NeoLumina Bioscience Inc. is a life sciences startup founded in 2018 with a mission to revolutionize mental health therapeutics. The company's slogan, "Advanced Therapeutics Inspired By Psychedelics," reflects its innovative approach. NeoLumina focuses on developing first-line therapeutics for a range of mental health disorders, including eating disorders, depression, anxiety, pain, and addictions.
With a commitment to leveraging breakthrough research, NeoLumina aims to address unmet needs in the mental health space. The startup's pioneering work at the intersection of life sciences and psychedelics positions it as a potential disruptor in the field. As the company continues to make advancements, it presents an intriguing opportunity for venture capital investors seeking to support groundbreaking initiatives in the biotech sector.
There is no investment information
No recent news or press coverage available for NeoLumina Bioscience Inc. .